3 Filipinos given prison terms for trafficking illicit drugs into S. Korea | Global News

3 Filipinos given prison terms for trafficking illicit drugs into S. Korea

/ 02:54 PM February 08, 2021

CHANGWON — Three Filipinos have been given prison terms for trafficking illegal drugs into South Korea, a local court said Monday.

The Changwon District Court, about 400 kilometers southeast of Seoul, recently sentenced the three Philippine nationals to three to five years in prison for violating the Narcotics Control Act.

The court has also handed down prison terms ranging from one to 2 1/2 years, suspended for two to four years, to three other Filipinos on the same charge.

Article continues after this advertisement

The six were indicted for smuggling 175.9 million won ($157,000) worth of narcotics, including methamphetamine and ecstasy, into the country on airplanes from March to August of last year.

FEATURED STORIES

The drugs were then delivered to a supermarket near their residence and distributed to different regions, sometimes hidden in cigarette boxes.

Some were found to have used the drugs themselves as well.

Article continues after this advertisement

“Drug trafficking can lead to a spread of illicit drug use here and have a profound negative impact on our society,” the court said, delivering the ruling. (Yonhap)

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Crime, drug trafficking, Global Nation, Illegal Drugs, Narcotics, Philippines, South Korea

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.